Joseph Payne

President & Chief Executive Officer Arcturus Therapeutics

Joseph E. Payne, is the President and Chief Executive Officer of Arcturus Therapeutics. He serves on Arcturus’s Board since March 2013. He brings with him an exceptional track record of ushering novel therapeutics to the clinic including targeted RNA medicines utilizing lipid-mediated delivery technologies. Joseph’s background includes over 20 years of successful drug discovery experience at Merck Research Labs, DuPont Pharmaceuticals, Bristol-Myers Squibb, Kalypsys, and Nitto as evidenced by over 40 publications and patents, and several investigational new drug (IND) clinical.

Seminars

Tuesday 22nd July 2025
CEO Think Tank: Unlocking the Next Wave of mRNA-Based Vaccines, Therapeutics & Platforms to Develop Better mRNA Drugs Towards Clinical Reality
9:00 am

Download the Full Event Guide to see session details.

Joseph Payne